04:43 PM EST, 02/07/2025 (MT Newswires) -- Alan J Russell, Director, Chief Scientific Officer, on February 05, 2025, sold 9,215 shares in Edgewise Therapeutics ( EWTX ) for $276,776. Following the Form 4 filing with the SEC, Russell has control over a total of 14,863 common shares of the company, with 14,863 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1710072/000156218025001026/xslF345X05/primarydocument.xml